However, our results showed that the oral administration of Se-Met at both low and high dosages for two weeks failed to prevent dopaminergic neuronal loss in the acute PD mice, as evidenced by the behavior results and TH expressions in mice midbrain. Here, TH is linked to Parkinson disease.